Health Catalyst Q2 Adj EPS $0.05 Up From $(0.03) YoY, Sales $73.21M Beat $72.63M Estimate
Portfolio Pulse from mahesh@benzinga.com
Health Catalyst (NASDAQ:HCAT) reported Q2 earnings of $0.05 per share, a 266.67% increase YoY. The company's quarterly sales were $73.21 million, beating the analyst consensus estimate of $72.63 million by 0.80% and marking a 3.65% increase over the same period last year.
August 08, 2023 | 9:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Health Catalyst's Q2 earnings and sales beat estimates, indicating a strong financial performance.
Health Catalyst reported a significant YoY increase in earnings and sales that beat analyst estimates. This strong financial performance is likely to positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100